One Of Biotech Industry’s Oldest Companies Has Never Secured A FDA Drug Approval–And It Was Just Dealt Another Rejection

The FDA's rejection of Immunomedics' drug designed to treat aggressive breast cancer cements a 37-year drug development drought for the biotech company. In other news, a FDA advisory panel splits over a decision on approving a diabetes drug.

from Kaiser Health News http://bit.ly/2Ct8sRF